172 related articles for article (PubMed ID: 14607063)
1. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma.
Bell A; Rickinson AB
Trends Microbiol; 2003 Nov; 11(11):495-7. PubMed ID: 14607063
[TBL] [Abstract][Full Text] [Related]
2. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
[TBL] [Abstract][Full Text] [Related]
3. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
[TBL] [Abstract][Full Text] [Related]
4. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.
Araujo I; Foss HD; Bittencourt A; Hummel M; Demel G; Mendonca N; Herbst H; Stein H
Blood; 1996 Jun; 87(12):5279-86. PubMed ID: 8652843
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
Kelly GL; Stylianou J; Rasaiyaah J; Wei W; Thomas W; Croom-Carter D; Kohler C; Spang R; Woodman C; Kellam P; Rickinson AB; Bell AI
J Virol; 2013 Mar; 87(5):2882-94. PubMed ID: 23269792
[TBL] [Abstract][Full Text] [Related]
7. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines.
Hernandez-Vargas H; Gruffat H; Cros MP; Diederichs A; Sirand C; Vargas-Ayala RC; Jay A; Durand G; Le Calvez-Kelm F; Herceg Z; Manet E; Wild CP; Tommasino M; Accardi R
Sci Rep; 2017 Jul; 7(1):5852. PubMed ID: 28724958
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
Vockerodt M; Tesch H; Kube D
Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features and Epstein-Barr virus infection status of Burkitt's lymphoma in Guangzhou district.
Huang YH; Wu QL; Zong YS; Feng YF; Liang JZ; Hou JH; Shao Q; Fu J
Ai Zheng; 2009 Aug; 28(8):805-12. PubMed ID: 19664325
[TBL] [Abstract][Full Text] [Related]
10. Burkitt's lymphoma in Brazil: strong association with Epstein-Barr virus.
Bacchi MM; Bacchi CE; Alvarenga M; Miranda R; Chen YY; Weiss LM
Mod Pathol; 1996 Jan; 9(1):63-7. PubMed ID: 8821959
[TBL] [Abstract][Full Text] [Related]
11. Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
Renouf B; Hollville E; Pujals A; Tétaud C; Garibal J; Wiels J
Leukemia; 2009 Sep; 23(9):1557-63. PubMed ID: 19421231
[TBL] [Abstract][Full Text] [Related]
12. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4.
Silins SL; Sculley TB
Int J Cancer; 1995 Jan; 60(1):65-72. PubMed ID: 7814154
[TBL] [Abstract][Full Text] [Related]
13. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
Klein SC; Jücker M; Abts H; Tesch H
Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
[TBL] [Abstract][Full Text] [Related]
14. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.
Anderton E; Yee J; Smith P; Crook T; White RE; Allday MJ
Oncogene; 2008 Jan; 27(4):421-33. PubMed ID: 17653091
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
16. TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.
Teitell MA; Lones MA; Perkins SL; Sanger WG; Cairo MS; Said JW
Am J Clin Pathol; 2005 Oct; 124(4):569-75. PubMed ID: 16146820
[TBL] [Abstract][Full Text] [Related]
17. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
Allday MJ
Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566
[TBL] [Abstract][Full Text] [Related]
18. The curious case of the tumour virus: 50 years of Burkitt's lymphoma.
Thorley-Lawson DA; Allday MJ
Nat Rev Microbiol; 2008 Dec; 6(12):913-24. PubMed ID: 19008891
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
20. Epstein barr virus IgG and EBER-1 in Burkitt's lymphoma children at a referral hospital in western Kenya.
Ndede I; Mining SK; Patel K; Wanjala FM; Tenge CN
Pan Afr Med J; 2019; 34():206. PubMed ID: 32180880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
